Your browser doesn't support javascript.
loading
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
Blando, Jorge; Sharma, Anu; Higa, Maria Gisela; Zhao, Hao; Vence, Luis; Yadav, Shalini S; Kim, Jiseong; Sepulveda, Alejandro M; Sharp, Michael; Maitra, Anirban; Wargo, Jennifer; Tetzlaff, Michael; Broaddus, Russell; Katz, Matthew H G; Varadhachary, Gauri R; Overman, Michael; Wang, Huamin; Yee, Cassian; Bernatchez, Chantale; Iacobuzio-Donahue, Christine; Basu, Sreyashi; Allison, James P; Sharma, Padmanee.
Afiliación
  • Blando J; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Sharma A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Higa MG; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Zhao H; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Vence L; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Yadav SS; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Kim J; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Sepulveda AM; Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, PA 19477.
  • Sharp M; Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, PA 19477.
  • Maitra A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Wargo J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Tetzlaff M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Broaddus R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Katz MHG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Varadhachary GR; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Overman M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Wang H; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Yee C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Iacobuzio-Donahue C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Basu S; David Rubenstein Pancreatic Cancer Research Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Allison JP; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Sharma P; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX 77054; jallison@mdanderson.org padsharma@mdanderson.org.
Proc Natl Acad Sci U S A ; 116(5): 1692-1697, 2019 01 29.
Article en En | MEDLINE | ID: mdl-30635425
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Linfocitos Infiltrantes de Tumor / Antígenos B7 / Melanoma Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Linfocitos Infiltrantes de Tumor / Antígenos B7 / Melanoma Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article